Screener
enGene Therapeutics Inc. ENGN Q1 2026 Annual earnings
Reported March 9, 2026 · Before market open
EPS-$0.44Beat by $0.11
EPS estimate-$0.55
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did enGene Therapeutics Inc. report Q1 2026 earnings?
- enGene Therapeutics Inc. (ENGN) reported Q1 2026 earnings on March 9, 2026 before market open.
- What were enGene Therapeutics Inc.'s Q1 2026 revenue and EPS?
- enGene Therapeutics Inc. reported eps of $-0.44 for Q1 2026.
- Did enGene Therapeutics Inc. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.55 by $0.11.
- How did enGene Therapeutics Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 8.3% from $-0.48.
- Where can I find enGene Therapeutics Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-097534) and the 10-K/A periodic report (0001193125-26-059409) directly on SEC EDGAR. The filing index links above go to sec.gov.
